Physicians' Academy for Cardiovascular Education

How early do we see the CVD benefits of LDL-C lowering?

5' education - Oct. 31, 2018 - Philip Barter, MD - University of New South Wales, Sydney, Australia

Prof. Philip Barter presents an analysis of the relationship between treatment duration and CVD benefits of different LDL-c lowering treatments.

Video navigation menu

  • Benefits of different statins in relation to treatment duration 00:24
  • Comparison of atorvastatin trials versus other statin trials 01:55
  • Does it matter how big the reduction in LDL-c or the primary endpoint is? 03:04
  • What is the effect of non-statins, ezetimibe and PCSK9 inhibitors? 03:46

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: